BCM
ALVOW icon

Bluefin Capital Management’s Alvotech Warrant ALVOW Stock Holding History

Bluefin Capital Management’s Portfolio ALVOW Stock Details ALVOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,608
Closed -$16.8K – 87
2025
Q2 		$16.8K Buy
+12,608
New +$22.3K 0.01% 120

Other funds holding ALVOW

OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $200M AUM 23.6% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bluefin Capital Management's ALVOW Position: Q3 2025 in Review

Bluefin Capital Management sold out of Alvotech Warrant (ALVOW) in Q3 2025, closing a stake of 12,608 shares — an estimated $16.8K sold.

Bluefin Capital Management first reported a position in ALVOW in Q2 2025 and held it in 1 quarter. The position peaked at $16.8K in Q2 2025. 9 funds tracked by Wall St. Rank hold ALVOW as of Q3 2025.

  • Bluefin Capital Management reported no remaining Alvotech Warrant position as of Q3 2025 after selling out during the quarter.
  • Bluefin Capital Management sold 12,608 Alvotech Warrant shares in Q3 2025, an estimated $16.8K.
  • Bluefin Capital Management first reported a position in Alvotech Warrant in Q2 2025 and held it in 1 quarter.
  • Bluefin Capital Management's Alvotech Warrant position peaked at $16.8K in Q2 2025.
  • 9 funds tracked by Wall St. Rank held Alvotech Warrant as of Q3 2025.

Based on Bluefin Capital Management's 13F filing for Q3 2025, filed 29 Apr 2026.